Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Dengue</strong> <strong>Vaccine</strong>s <strong>Market</strong>: Global Industry Analysis and<br />
Opportunity Assessment, 2017-2027<br />
May2017<br />
Report Id : REP-GB-1763<br />
Status : March-2017<br />
Category : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom<br />
research reports, and consulting services. We deliver a complete packaged solution, which<br />
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth<br />
insights, aerial view of the competitive framework, and future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC,<br />
ASEAN, and BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,<br />
Technology, Healthcare, and Retail.<br />
We have a global presence with delivery centers across India specializing in providing global<br />
research reports and country research reports. FMI is headquartered out of London, U.K., with a<br />
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning<br />
from every corner of the world to distill it to one thing – the perfect solution for our client.<br />
Research Capabilities<br />
Sector Coverage<br />
<br />
<br />
<br />
<br />
Customized Research<br />
Syndicated Research<br />
Investment Research<br />
Social Media Research<br />
<br />
<br />
<br />
<br />
Automotive and Transportation<br />
Electronics, Semiconductor, and ICT<br />
Retail and Consumer Products<br />
Industrial Automation and Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & Materials<br />
Food and Beverages<br />
Services and Utilities<br />
Energy, Mining, Oil, and Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
Research Methodology (1/2)<br />
Systematic Research Approach<br />
<strong>Market</strong> profiling<br />
Formulating discussion guide<br />
Developing list of respondents<br />
Data collection<br />
Data validation<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used to<br />
ascertain overall market size, top<br />
industry players, top products, industry<br />
associations, etc.<br />
PMR formulates a detailed discussion<br />
guide to conduct expert and industry<br />
interviews<br />
PMR develops a list of industry players<br />
(manufacturers), distributors, retailers<br />
and industry experts<br />
PMR conducts interviews with industry<br />
experts, industry players, distributors<br />
and retailers<br />
Data is validated by triangulation<br />
method, wherein secondary, primary<br />
and PMR analysis contribute to the final<br />
data<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Data<br />
Collection<br />
Data Filter<br />
& Analysis<br />
Identifying key opinion leaders<br />
Questionnaire design<br />
In-depth interviews<br />
Coverage across value chain<br />
<strong>Market</strong> participants<br />
Key strengths<br />
Product portfolio<br />
Mapping as per value chain<br />
Key focus segments<br />
A<br />
Primary<br />
Research<br />
C<br />
Company<br />
Analysis<br />
Research &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
Research<br />
<br />
<br />
<br />
<br />
<br />
<br />
Business<br />
Solution<br />
Key industry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
Products<br />
Conclusions<br />
Data analysis<br />
6<br />
Data is scrutinized using MS-Excel to<br />
obtain qualitative and quantitative<br />
insights about the industry<br />
Primary Research #<br />
Secondary Research #<br />
Paid Publications#<br />
Insights<br />
7<br />
PMR delivers industry insights and<br />
information in the required format<br />
(PDF)<br />
<br />
<br />
<br />
<br />
Linkedin<br />
Zoominfo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
Financial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltwater<br />
# includes sources of databases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
<strong>Dengue</strong> <strong>Vaccine</strong> <strong>Market</strong><br />
Burdening occurrence of dengue fever across the Asia-Pacific region has prompted the demand for effective<br />
vaccines and medications to supress this viral malaise. While several pharmaceutical companies are striving<br />
to develop a cure for dengue, the fever’s incidence rate in Asia-Pacific is rising at an alarming rate. A recent<br />
report published by Future <strong>Market</strong> Insights predicts that in 2017, an estimated 70.3% of global dengue<br />
vaccines market will be dominated by Asia-Pacific. Through 2027, the region will continue to be the largest<br />
market for dengue vaccines, procuring a majority revenue share and projecting revenue growth at a 17.4%<br />
CAGR.<br />
Future <strong>Market</strong> Insights also observes Latin America as the second-largest market for dengue vaccines, and is<br />
expected to rake in US$ 288.7 Mn towards the end of 2027. The report, titled “<strong>Dengue</strong> <strong>Vaccine</strong>s <strong>Market</strong>:<br />
Global Industry Analysis and Opportunity Assessment, 2017-2027,” expects that more and more<br />
pharmaceutical giants from across the globe will be partaking in the market’s growth in the years to come.<br />
Currently, the market is witnessing active participation of French drugmaker, Sanofi S.A., while vaccines<br />
being formulated by companies such as Biological E. Limited, Takeda Pharmaceutical Company Limited,<br />
GlaxoSmithKline plc, Merck & Co. Inc., Vabiotech, Butantan Institute, and Panacea Biotech Ltd. are under<br />
multiple phases of development.<br />
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1763<br />
The report further reveals that government institutes will remain the largest end-users of dengue vaccines in<br />
the world. Through 2027, a little less than US$ 650 Mn worth of revenues is expected to arise from sales of<br />
dengue vaccines across government institutes. Meanwhile, hospitals will also dominate the market by<br />
registering a 17.3% revenue CAGR. The market, at present, will witness sales of the sole of vaccine,<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
<strong>Dengue</strong> <strong>Vaccine</strong> <strong>Market</strong><br />
Dengvaxia, developed by Sanofi. Furthermore, factors shaping up the dynamics of global dengue vaccines<br />
market, also compiled in the report, are:<br />
Apart from the burdening outbreak of dengue in several countries, the economic turmoil in Latin America<br />
is projected to impact the global market’s growth at a macroeconomic level<br />
Live attenuated vaccines are being developed & produced economically, thereby comforting vaccine<br />
makers as well as patients<br />
However, lack of skilled professionals and unavailability of optimum diagnostic systems has given rise to<br />
cases where dengue fever is being treated as an undistinguished febrile disease<br />
The global market for dengue vaccines holds an opportunistic breakthrough when drugmakers will be<br />
able to successfully develop effective vaccines for all age group<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
Table of Content<br />
1. Executive Summary<br />
2. <strong>Market</strong> Introduction<br />
2.1. <strong>Market</strong> Taxonomy<br />
3. Global <strong>Dengue</strong> <strong>Vaccine</strong> <strong>Market</strong> Analysis Scenario<br />
3.1. <strong>Market</strong> Size (US$ Mn) and Forecast<br />
3.1.1. <strong>Market</strong> Size and Y-o-Y Growth<br />
3.1.2. Absolute $ Opportunity<br />
3.2. <strong>Market</strong> Overview<br />
4. <strong>Market</strong> Dynamics and USPs<br />
4.1. Macro-economic Factors<br />
4.2. Drivers<br />
4.2.1. Supply Side<br />
4.2.2. Demand Side<br />
4.3. Restraints<br />
4.4. Opportunity<br />
4.5. Trends<br />
4.6. <strong>Dengue</strong> <strong>Vaccine</strong> Research Pipeline Analysis<br />
4.7. Global <strong>Dengue</strong> <strong>Vaccine</strong> <strong>Market</strong>: Funding Scenario<br />
4.8. Global <strong>Dengue</strong> <strong>Vaccine</strong> <strong>Market</strong>: <strong>Dengue</strong> Epidemiology Analysis<br />
4.9. Global <strong>Dengue</strong> <strong>Vaccine</strong> <strong>Market</strong>: Dengvaxia SWOT<br />
4.10. Global <strong>Dengue</strong> <strong>Vaccine</strong> <strong>Market</strong>: Dengvaxia Promotional Activities<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
6
Table of Content<br />
5. Global <strong>Dengue</strong> <strong>Vaccine</strong> Opportunity Analysis and Forecasts, By End User<br />
5.1. Introduction<br />
5.2. Basis Point Share (BPS) Analysis By End User<br />
5.3. Y-o-Y Growth Projections By End User<br />
5.4. <strong>Market</strong> Value Forecast By End User, 2017–2027<br />
5.4.1. Hospitals<br />
5.4.2. Government Institutes<br />
5.4.3. NGOs<br />
5.5. Prominent Trends<br />
5.6. <strong>Market</strong> Attractiveness By End User<br />
6. Global <strong>Dengue</strong> <strong>Vaccine</strong> Opportunity Analysis and Forecasts, By Region<br />
6.1. Basis Point Share (BPS) Analysis By Region<br />
6.2. Y-o-Y Growth Projections By Region<br />
6.3. <strong>Market</strong> Value Forecast By Region<br />
6.3.1. Latin America<br />
6.3.2. Asia Pacific<br />
6.3.3. Middle East and Africa (MEA)<br />
6.3.4. Rest of the World (RoW)<br />
6.4. <strong>Market</strong> Attractiveness By Region<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
7
Table of Content<br />
7. Latin America <strong>Dengue</strong> <strong>Vaccine</strong> Opportunity Analysis and Forecast<br />
7.1. Introduction<br />
7.1.1. Basis Point Share (BPS) Analysis By Country<br />
7.1.2. Y-o-Y Growth Projections By Country<br />
7.2. <strong>Market</strong> Value Forecast By, 2016–2026<br />
7.3. <strong>Market</strong> Value Forecast By End User, 2016–2026<br />
7.3.1. Hospitals<br />
7.3.2. Government Institutes<br />
7.3.3. NGOs<br />
7.4. <strong>Market</strong> Value Forecast By Country, 2016–2026<br />
7.4.1. Brazil<br />
7.4.2. Mexico<br />
7.4.3. Venezuela<br />
7.4.4. Rest of Latin America<br />
7.5. <strong>Market</strong> Attractiveness Analysis<br />
7.5.1. By End User<br />
7.5.2. By Country<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
8
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For media queries, contact the press office at<br />
press@futuremarketinsights.com<br />
For other queries contact:<br />
Hari. T (Sr. Manager - Global Business Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consulting Private Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
9
Change language